Skip to main navigation Skip to search Skip to main content

A Phase 2, randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Exploratory Study to Evaluate Effects of VX-661 in Combination with Ivacaftor on Lung and Extrapulmonary Systems in Subjects Aged 18 Years and Older With Cystis Fibros

Project: Research

Project Details

StatusFinished
Effective start/end date09/8/15 → 07/31/17

Funding

  • Vertex Pharmaceuticals Incorporated: $63,324.00